Does antidepressant use in pregnancy raise ADHD risk?

Antidepressants in pregnancy and child ADHD/autism risk

A new study found little to no association between taking antidepressants before or during pregnancy and later diagnoses of attention-deficit/hyperactivity disorder (ADHD) or autism in children.

Researchers looked at antidepressant exposure around the time of pregnancy and then examined whether offspring had higher odds of ADHD or autism compared with unexposed pregnancies. The overall message is that the feared link to these neurodevelopmental outcomes was not supported by the data.

The findings matter because concerns have grown in recent years about whether antidepressants could harm fetal brain development, especially after public anxiety intensified around potential neurodevelopmental effects. Clinicians and patients often need evidence that balances benefits—such as treating depression during pregnancy—with any realistic long-term risks to children.

Importantly, the report’s framing emphasizes that risk is likely influenced by other factors beyond medication exposure. These can include a child’s genetic predisposition to mental health conditions.

For patients, the takeaway is not that antidepressants are risk-free, but that this particular study did not find a meaningful signal for increased ADHD or autism risk tied to exposure during pregnancy. That may help guide shared decision-making when considering whether to continue, start, or adjust antidepressant treatment during pregnancy.

If you’re using antidepressants during pregnancy or considering treatment, discussion with a healthcare professional remains essential—especially because depression can itself affect pregnancy and postpartum health. The study does not replace individualized care, but it provides clearer evidence for one of the commonly raised safety concerns.